Visitors Now:
Total Visits:
Total Stories:
Profile image
By Children Of Vietnam Veterans Health Alliance
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Agent Orange Chemical Companies Continue Building Monopolies

Wednesday, November 16, 2016 17:17
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Agent Orange Advocacy http://covvha.net/

The Chemical Companies responsible for Agent Orange and Genetically Modified Seeds continue their bid to merge into mega monopolies. The merger between Dow and DuPont is almost a year in the making, as it was announced in late 2015. Recently, Monsanto Corp. announced it was being purchased by Bayer. Both Dow and Monsanto were contracted by the D.O.D to manufacture the chemical herbicide Agent Orange. Agent Orange is responsible for killing and sicking those exposed. It is strongly suspected to have caused birth defects and ailments in the offspring of those exposed.

9439985_g

Bloomberg
November 15, 2016

Dow Chemical Co. and DuPont Co. are expecting to get formal objections to their $60 billion merger from European Union regulators as soon as next month, listing potential antitrust concerns with their bid to form the world’s biggest chemical company, according to two people familiar with the investigation.

The European Commission in Brussels is poised to send the complaint to the companies in December, according to people who asked not to be named because the process is confidential. It may lay out how the transaction could reduce competition in areas such as crop protection, seeds and certain petrochemicals.

The merger is among a trio of pending deals — including Bayer AG’s agreement to buy Monsanto Co. and China National Chemical Corp.’s agreement to buy Syngenta AG — that could reshape the agricultural-chemicals industry. EU Competition Commissioner Margrethe Vestager has warned that the deals could leave the sector “quite concentrated.”

“I think we are looking at a process where Dow-DuPont is in much more trouble than the other two deals,” said Alan Riley, senior fellow at the Institute for Statecraft, a London-based think tank. “They are both funding R&D in the same fields so there is a real issue of innovation loss from the deal” that might be difficult to eliminate with guarantees to regulators promising good behavior.

Dow-DuPont was the first to get an extended probe by the EU and now has a Feb. 28 deadline for a final decision. Regulators last month also opened a longer investigation of China National Chemical’s bid for Switzerland’s Syngenta. Bayer is yet to file for EU approval to buy Monsanto.

Click Here for the remainder of the article

(COVVHA) Children of Vietnam Veterans Health Alliance INC. AO2GEN

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.